BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia (Q41980844)
Jump to navigation
Jump to search
scientific article published on 14 August 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia |
scientific article published on 14 August 2014 |
Statements
1 reference
BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia (English)
1 reference
1 reference
1 reference
Hagop Kantarjian
1 reference
Gianantonio Rosti
1 reference
Michele Baccarani
1 reference
Marina Konopleva
1 reference
Jorge E Cortes
1 reference
Elias J Jabbour
1 reference
Steven M Kornblau
1 reference
Meir Wetzler
1 reference
Charles Chuah
1 reference
Hanna J Khoury
1 reference
Franck E Nicolini
1 reference
Leif Stenke
1 reference
Gert J Ossenkoppele
1 reference
Francois-Xavier Mahon
1 reference
Philippe Rousselot
1 reference
Thoralf Lange
1 reference
Christopher A Eide
1 reference
Matthew S Zabriskie
1 reference
Srinivas K Tantravahi
1 reference
Nadeem A Vellore
1 reference
Johanna Estrada
1 reference
Jeffrey H Lipton
1 reference
Gisela Barbany
1 reference
Juan-Carlos Hernández-Boluda
1 reference
Stuart L Goldberg
1 reference
Gabriel Etienne
1 reference
Ran Friedman
1 reference
Marie Deininger
1 reference
Kimberly R Reynolds
1 reference
William L Heaton
1 reference
Anthony D Pomicter
1 reference
Jamshid S Khorashad
1 reference
Todd W Kelley
1 reference
Riccardo Baron
1 reference
Michael W Deininger
1 reference
Thomas O'Hare
1 reference
14 August 2014
1 reference
1 reference
428-442
1 reference
Identifiers
1 reference
1 reference
1 reference